Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 3/20 | 0.41 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.40 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.40 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.39 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21142427 | 0.87 | MAPT (0.43) | HSD17B10KDM4EMAPTHIF1AALDH1A1 | |
| SCHEMBL10148193 | 0.82 | MAPT (0.52) | HSD17B10KDM4EMAPTHIF1AALDH1A1 | |
| SCHEMBL11985092 | 0.77 | TSHR (0.38) | TSHR | |
| SCHEMBL19478610 | 0.76 | MAPT (0.46) | HSD17B10KDM4EMAPTHIF1AALDH1A1 | |
| SCHEMBL23870602 | 0.74 | TSHR (0.44) | HSD17B10KDM4EMAPTALDH1A1TSHR | |
| SCHEMBL12386879 | 0.74 | TSHR (0.48) | HSD17B10KDM4EMAPTALDH1A1TSHR | |
| SCHEMBL21895250 | 0.73 | TSHR (0.39) | HSD17B10KDM4EMAPTHIF1AALDH1A1 | |
| SCHEMBL19201190 | 0.72 | TSHR (0.43) | MAPTALDH1A1TSHRKMT2AMEN1 | |
| SCHEMBL762893 | 0.71 | KMT2A (0.56) | HSD17B10KDM4EMAPTHIF1AALDH1A1 | |
| SCHEMBL21976700 | 0.70 | CYP1A2 (0.69) | HSD17B10MAPTALDH1A1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230023961-A1 | MITE INFESTATION TREATMENT | VETO-PHARMA (FR) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230023961-A1 | MITE INFESTATION TREATMENT | RHOA, NPEPPS, TUBA3E | HSD17B10 2468/4885KDM4E 726/4885MAPT 659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.